Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Vomiting × Olanzapine × Clear all

Phase

Status

Unknown 5 Completed 5 Recruiting 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

peppermint oil 1 fosaprepitant 1 almond oil 1 Standard of Care 1 Palonosetron 1 Olanzapine 1 Growth Differentiation Factor 15 1 Fecal Microbiota Transplantation 1 Aprepitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07035821 2025-06-25

Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

Shanghai Children's Medical Center

Phase 3 Not yet recruiting

Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡